Program (프로그램)
| Time | Title | Speaker |
|---|---|---|
| 10:00 - 10:05 (05') | Opening Remark | Kyu-Sung Lee Director, Research Institute for Future Medicine, Samsung Medical Center |
| 10:05 - 10:10 (05') | Congratulatory address | Seung Woo Park President of Samsung Medical Center |
| 10:10 - 10:15 (05') | Congratulatory address | Soon Koo Baik President of Wonju Severance Christian Hospital |
| 10:15 - 10:20 (05’) | Congratulatory address | Hwang Eui Su Director, Division of Health Industry Policy, Ministry of Health and Welfare |
| 10:20 - 10:30 (10') | K-DEM Station: Current Status and Achievements | Hong Jin Jeon Samsung Medical Center |
| Session 1 | Development and Commercialization of Digital Therapeutics (10:30 ~ 12:35) |
Chair : Hong Jin Jeon, Samsung Medical Center |
| 10:30 - 10:55 (25') | Scaling DTx for mental health to thousands of patients with anxiety disorders - The Sympatient story | Christian Philipp AngernCV Co-Founder, Sympatient |
| 10:55 - 11:20 (25') | Development and Commercialization of Digital Therapeutics for CGM-based Automated Insulin Delivery | Sang Man JinCV Professor, Samsung Medical Center |
| 11:20 - 11:45 (25') | Clinical Application of Digital Therapeutics in Pediatric Allergic Diseases | Kangmo AhnCV Professor, Samsung Medical Center |
| 11:45 - 12:10 (25’) | Go-to-Market strategy of WELT-i (DTx for Insomnia) | Seong-ji KangCV MD, MPH, WELT |
| 12:10 - 12:35 (25') | Move and play, It will Diagnose and Treat MCI | Sang Yeol YongCV Professor, Wonju Severance Christian Hospital |
| 12:35 - 13:30 (55') | Break time / Lunch | |
| Session 2 | Electroceuticals - Paradigm Shift in the Treatment of Chronic/Intractable Diseases (13:30 ~ 15:50) |
Chair : Young Min Shon, Samsung Medical Center |
| 13:30 - 13:55 (25') | NaviNetics, Inc : Bench to Business to Bedside |
Kendall H. Lee, M.D., Ph.D.CV Professor, Mayo Clinic & Co-CEO, CMO, NaviNetics Yoonbae Oh, Ph.D.CV Associate professor, Mayo Clinic & Vice president, NaviNetics |
| 13:55 - 14:20 (25') | Next-Generation Smart DBS and Neuromodulation: Elucidating Mechanism of Action of DBS in Drug Addiction |
Kendall H. Lee, M.D., Ph.D. CV Professor, Mayo Clinic & Co-CEO, CMO, NaviNetics Hojin Shin, Ph.D.CV Assistant Professor, Mayo Clinic |
| 14:20 - 14:45 (25') | Electroceuticals for Ocular Surface Diseases to Promote Nerve Function Recovery | Dong Hui LimCV Professor, Samsung Medical Center |
| 14:45 - 15:10 (25') | Analyzing Digital Biomarker of Neuromuscular Disorders for Personalized Electroceuticals | Hooman LeeCV CEO, EXOSYSTEMS |
| 15:10 - 15:35 (25') | Electroceuticals for Functional Recovery after Spinal Cord Injury | Jung Keun HyunCV Professor, Dankook University Medical Center |
| 15:35 - 15:50 (15’) | Break Time | |
| Session 3 | Successful Market Entry Strategies for Digital & Electronic Therapeutics (15:50 ~ 17:30) | Chair : Woo Seong Huh, Samsung Medical Center |
| 15:50 - 16:10 (20') | DTx Regulation and Successful Case | Young Min HanCV Assistant Director, Ministry of Food and Drug Safety |
| 16:10 - 16:30 (20') | Introduction to Reimbursement Coverage and Pricing Rules for DTx | Yong Woo KimCV CEO, MDREX |
| 16:30 - 16:50 (20') | Application of Decentralized Clinical Trials of Digital Therapeutics | Hae Sook BokCV Team Leader, A-CRO, Samsung Medical Center |
| 16:50 - 17:10 (20') | Case Studies of Support for the Productization of Digital and Electronic Medical Devices | Young-Jin KimCV Principal Researcher, Dept. of R&D, KBIOHEALTH |
| 17:10 - 17:30 (20') | Differences between Digital Healthcare Services, Digital Therapeutics, and Telemedicine and Essential elements for Successful Market entry of Digital Treatment Devices | Changheon OhCV CEO, Foresight Company Co. Ltd. |
| CLOSING | ||
|
10:00 - 10:05 (05') Opening Remark Kyu-Sung Lee (Director, Research Institute for Future Medicine, Samsung Medical Center) |
|
10:05 - 10:10 (05') Congratulatory address Seung Woo Park (President of Wonju Severance Christian Hospital) |
|
10:10 - 10:15 (05') Congratulatory address Soon Koo Baik (President of Wonju Severance Christian Hospital) |
|
10:15 - 10:20 (05’) Congratulatory address Hwang Eui Su (Director, Division of Health Industry Policy, Ministry of Health and Welfare) |
|
10:20 - 10:30 (10') K-DEM Station: Current Status and Achievements Hong Jin Jeon (Samsung Medical Center) |
|
Session 1 Development and Commercialization of Digital Therapeutics (10:30 ~ 12:35) Chair : Hong Jin Jeon, |
|
10:30 - 10:55 (25') Scaling DTx for mental health to thousands of patients with anxiety disorders - The Sympatient story Christian Philipp Angern (Co-Founder, Sympatient)CV |
|
10:55 - 11:20 (25') Development and Commercialization of Digital Therapeutics for CGM-based Automated Insulin Delivery Hong Jin Jeon (CEO, Meditrix/Professor, Samsung Medical Center)CV |
|
11:20 - 11:45 (25') Clinical Application of Digital Therapeutics in Pediatric Allergic Diseases Kangmo Ahn (Professor, Samsung Medical Center)CV |
|
11:45 - 12:10 (25’) Go-to-Market strategy of WELT-i (DTx for Insomnia) Seong-ji Kang (MD, MPH, WELT)CV |
|
12:10 - 12:35 (25') Move and play, It will Diagnose and Treat MCI Sang Yeol Yong (Professor, Wonju Severance Christian Hospital)CV |
|
12:35 - 13:30 (55') Break time / Lunch |
|
Session 2 Electroceuticals - Paradigm Shift in the Treatment of Chronic/Intractable Diseases (13:30 ~ 15:50) Chair : Young Min Shon, |
|
13:30 - 13:55 (25') NaviNetics, Inc : Bench to Business to Bedside Kendall H., M.D., Ph.D., (Professor, Mayo Clinic & Co-CEO, CMO, NaviNetics)CV Yoonbae Oh, Ph.D.(Associate professor, Mayo Clinic & Vice president, NaviNetics)CV |
|
13:55 - 14:20 (25') Next-Generation Smart DBS and Neuromodulation: Elucidating Mechanism of Action of DBS in Drug Addiction Kendall H., M.D., Ph.D., (Professor, Mayo Clinic & Co-CEO, CMO, NaviNetics)CV Hojin Shin, Ph.D. (Assistant Professor, Mayo Clinic)CV |
|
14:20 - 14:45 (25') Electroceuticals for Ocular Surface Diseases to Promote Nerve Function Recovery Dong Hui Lim (Professor, Samsung Medical Center)CV |
|
14:45 - 15:10 (25') Analyzing Digital Biomarker of Neuromuscular Disorders for Personalized Electroceuticals Hooman Lee (CEO, EXOSYSTEMS)CV |
|
15:10 - 15:35 (25') Electroceuticals for Functional Recovery after Spinal Cord Injury Jung Keun Hyun (Professor, Dankook University Medical Center)CV |
|
15:35 - 15:50 (15’) Break Time |
|
Session 3 Successful Market Entry Strategies for Digital & Electronic Therapeutics Chair : Woo Seong Huh |
|
15:50 - 16:10 (20') DTx Regulation and Successful Case Han Young Min (Assistant Director, Ministry of Food and Drug Safety)CV |
|
16:10 - 16:30 (20') Introduction to Reimbursement Coverage and Pricing Rules for DTx Yong Woo Kim (CEO, MDREX)CV |
|
16:30 - 16:50 (20') Application of Decentralized Clinical Trials of Digital Therapeutics Hae Sook Bok (Team Leader, A-CRO, Samsung Medical Center)CV |
|
16:50 - 17:10 (20') Case Studies of Support for the Productization of Digital and Electronic Medical Devices Young-Jin Kim (Principal Researcher, Dept. of R&D, KBIOHEALTH)CV |
|
17:10 - 17:30 (20') Differences between Digital Healthcare Services, Digital Therapeutics, and Telemedicine and Essential elements for Successful Market entry of Digital Treatment Devices Changheon Oh (CEO, Foresight Company Co. Ltd.)CV |
|
17:30 - CLOSING |
| 시간 | 연제 | 연자 |
|---|---|---|
| 09:00 - 09:05 (05') | 인사말 | 허우성 연구부원장 삼성서울병원 |
| 09:05 - 09:10 (05') | 축사 | 박승우 원장 삼성서울병원 |
| 09:10 - 09:15 (05') | 축사 | 어영 원장 원주세브란스기독병원 |
| 09:15 - 09:20 (05’) | 축사 | 정은영 보건복지부 |
| 09:20 - 09:30 (10') | K-DEM 성과 발표 | 전홍진 센터장 삼성서울병원 디지털치료연구센터 |
| Session 1 | 디지털 치료와 혁신 기술의 융합 (09:30 ~ 11:45) |
좌장 : 전홍진 센터장 삼성서울병원 디지털치료연구센터 |
| 09:30 - 10:30 (60') | Virtual Reality in Older Adults with Mental Illness | Alva LuttCV - |
| Movement as a Digital Biomarker: Linking Psychomotor Function in Depression to Inflammation and Dopaminergic Modulation | Woo-ri ChaeCV - | |
| 10:30 - 10:55 (25') | TBD | 강성지 대표CV 웰트 |
| 10:55 - 11:20 (25') | TBD | 이준영 대표 CV 이모코그 |
| 11:20 - 11:45 (25') | TBD | 김대현 대표 CV ㈜비욘드메디슨 |
| 11:45 - 12:45 (60') | Break time / Lunch | |
| Session 2 | 차세대 전자약의 임상 적용과 미래 (12:45 ~ 14:40) |
좌장 : 손영민 연구소장 삼성서울병원 스마트헬스케어연구소 |
| 12:45 - 13:10 (25') | 뇌 네트워크 디코딩을 통한 뇌 상태의 정밀 규명 |
이세호 교수 CV 울산대학교 ICT융합학부 |
| 13:10 - 13:35 (25') | TBD | 정하철 대표 CV 택로봇(TacRobot) |
| 13:35 - 14:00 (25') | TBD | TBD CV |
| 14:00 - 14:25 (25') | TBD | TBDCV |
| 14:25 - 14:40 (15’) | Break Time | |
| Session 3 | 디혁신 기술의 사업화와 확산 (14:40 ~ 16:20) |
좌장: 김성훈 |
| 14:40 - 15:05 (25') | 디지털의료기기 사이버보안 관련 국내외 동향 및 국내 인허가 대응 방안 | 박상신 팀장 CV 한국정보통신기술협회 |
| 15:05 - 15:30 (25') | TBD | 김영CV |
| 15:30 - 15:55 (25') | 디지털의료기기 사용적합성의 주요 특성 | 김우겸 선임 CV 삼성서울병원 사용자적합성평가센터 |
| 15:55 - 16:20 (25') | TBD | 엄수혁CV DNV |
| CLOSING | ||
|
09:00 - 09:05 (05') 인사말 허우성 연구부원장 (삼성서울병원) |
|
09:05 - 09:10 (05') 축사 박승우 원장 (삼성서울병원) |
|
09:10 - 09:15 (05') 축사 어영 원장 (원주세브란스기독병원) |
|
09:15 - 09:20 (05’) 축사 정은영 (보건복지부) |
|
09:20 - 09:30 (10') 삼성서울병원 연구중심병원 3유닛 K-DEM개발 현황 및 성과 전홍진 센터장 (삼성서울병원 디지털치료연구센터) |
|
Session 1 디지털 치료와 혁신 기술의 융합 좌장 : 전홍진 센터장, 삼성서울병원 디지털치료연구센터 |
|
09:30 - 10:30 (60') Virtual Reality in Older Adults with Mental Illness Alva Lutt, ( - )CV Movement as a Digital Biomarker: Linking Psychomotor Function in Depression to Inflammation and Dopaminergic Modulation Woo-ri Chae ( - )CV |
|
10:30 – 10:55 (25') TBD 강성지 대표 (웰트)CV |
|
10:55 – 11:20 (25') TBD 이준영 대표 (이모코그)CV |
|
11:20 - 11:45 (25’) TBD 김대현 대표 (㈜비욘드메디슨)CV |
|
11:45 - 12:45 (60') Break time / Lunch |
|
Session 2 차세대 전자약의 임상 적용과 미래 좌장 : 손영민 연구소장, 삼성서울병원 스마트헬스케어연구소 |
|
12:45 – 13:10 (25') 뇌 네트워크 디코딩을 통한 뇌 상태의 정밀 규명 이세호 교수 (울산대학교 ICT융합학부)CV |
|
13:10 - 13:35 (25') TBD 정하철 대표 (TacRobot)CV |
|
13:35 - 14:00 (25') TBD TBDCV |
|
14:00 - 14:25 (25') TBD TBD CV |
|
14:25 – 14:40 (15’) Break Time |
|
Session 3 혁신 기술의 사업화와 확산 (14:40 ~ 16:20) 좌장: 김성훈 |
|
14:40 - 15:05 (25') 디지털의료기기 사이버보안 관련 국내외 동향 및 국내 인허가 대응 방안 박상신 팀장 (한국정보통신기술협회)CV |
|
15:05 - 15:30 (25') TBD 김영CV |
|
15:30 - 15:55 (25') 디지털의료기기 사용적합성의 주요 특성 김우겸 선임 (삼성서울병원 사용자적합성평가센터)CV |
|
15:55 - 16:20 (25') TBD 엄수혁 (DNV)CV |
|
CLOSING |
Login (강연 시청)